Suppr超能文献

替加色罗可加速以便秘为主的肠易激综合征患者的口盲肠转运。

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.

作者信息

Prather C M, Camilleri M, Zinsmeister A R, McKinzie S, Thomforde G

机构信息

Gastroenterology Research Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.

出版信息

Gastroenterology. 2000 Mar;118(3):463-8. doi: 10.1016/s0016-5085(00)70251-4.

Abstract

BACKGROUND & AIMS: This study evaluated the effects of a partial 5-hydroxytryptamine (5-HT)(4) agonist, tegaserod, on gastric small bowel and colonic transit in constipation-predominant irritable bowel syndrome (IBS).

METHODS

After a 1 week run-in period, 24 patients with constipation-predominant IBS were randomized to 1 week of tegaserod, 2 mg twice daily, or placebo treatment. Scintigraphic gastric emptying, small bowel transit, and colonic transit were determined before administration of study drug and after 1 week on the medication. Colonic transit was also measured using radiopaque markers and a single radiograph on day 5.

RESULTS

Gastric emptying was unaltered by tegaserod. Proximal colonic filling at 6 hours, a measure of orocecal transit, was accelerated by tegaserod (70.4% +/- 1.3% [mean +/- SEM] vs. placebo, 46.4 +/- 1.9; P = 0.015). Proximal colonic emptying half-time and geometric center at 48 hours were also accelerated by tegaserod compared with baseline, but not compared with placebo. Mean colonic transit time was similar in both groups at baseline and after drug administration (tegaserod, 59.5 +/- 2.1 hours; placebo, 62.1 +/- 2.1 hours).

CONCLUSIONS

Tegaserod accelerates orocecal transit, tends to accelerate colonic transit, and deserves further study in patients with constipation-predominant IBS.

摘要

背景与目的

本研究评估了部分5-羟色胺(5-HT)(4)激动剂替加色罗对以便秘为主的肠易激综合征(IBS)患者胃、小肠和结肠转运的影响。

方法

经过1周的导入期后,24例以便秘为主的IBS患者被随机分为两组,分别接受为期1周的替加色罗治疗(每日2次,每次2 mg)或安慰剂治疗。在服用研究药物前及用药1周后,通过闪烁扫描法测定胃排空、小肠转运和结肠转运情况。在第5天,还使用不透X线标志物和单次X光片测量结肠转运。

结果

替加色罗未改变胃排空情况。替加色罗可加速6小时时近端结肠充盈,这是口盲肠转运的一项指标(70.4%±1.3%[平均值±标准误],而安慰剂组为46.4±1.9;P = 0.015)。与基线相比,替加色罗也加速了48小时时近端结肠排空半衰期和几何中心,但与安慰剂组相比无差异。两组在基线和用药后平均结肠转运时间相似(替加色罗组为59.5±2.1小时;安慰剂组为62.1±2.1小时)。

结论

替加色罗可加速口盲肠转运,倾向于加速结肠转运,在以便秘为主的IBS患者中值得进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验